Depressive Episode Clinical Trial
Official title:
Role Of Non-Specific Effects in The Treatment of Depression With Esketamine
The investigators aim to examine the magnitude of non-specific effects in the treatment of depressive episodes with esketamine, by providing patients in the intervention group with a pretreatment presentation and post-treatment follow up session, to assess whether nonspecific effects can be used effectively to improve the effectiveness of treatment with esketamine.
Primary Objective: To determine whether a positive presentation before first treatment improves expectation of improvement from treatment in patients receiving esketamine for a depressive episode within 24 hours after the first treatment. Secondary Objectives: To determine whether a post-treatment follow up session to provide encouragement and reassurance improves expectation of improvement from treatment in patients receiving esketamine for a depressive episode within 24 hours after the first treatment. To determine whether a positive presentation results in an improved response from treatment in patients receiving esketamine for a depressive episode as measured by MADRS score within 24 hours after the first treatment. To determine whether a positive presentation before first treatment, combined with a posttreatment follow up session after first treatment, result in an improved response from treatment in patients receiving esketamine for a depressive episode as measured by MADRS score by the end of the acute course of esketamine treatment. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04469322 -
Pharmacogenetic Implementation Trial in Veterans With Treatment Refractory Depression
|
N/A | |
| Recruiting |
NCT02481245 -
BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study
|
Phase 2 | |
| Completed |
NCT03449979 -
Single Session of tACS in a Depressive Episode
|
N/A | |
| Recruiting |
NCT05708222 -
Sleep Signal Analysis for Current Major Depressive Episode (SAMDE)
|
||
| Completed |
NCT01879111 -
Increasing the Efficiency of Depression-screening Using Patient-targeted Feedback
|
N/A | |
| Unknown status |
NCT01212848 -
Transcranial Magnetic Stimulation (TMS) for Suicidal Ideation
|
Phase 3 | |
| Not yet recruiting |
NCT05547711 -
Prediction and Validation of Unipolar Depression With Psychosocial-somatic Markers in a Naturalistic Cohort Recruited in an Outpatient Setting
|
N/A | |
| Completed |
NCT04239521 -
The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
|
||
| Completed |
NCT03288714 -
Adaptive Design Study of NEST sTMS in Subjects With Major Depressive Disorder
|
N/A | |
| Completed |
NCT03899168 -
Confirmation Bias Towards Treatments of Depressive Disorders in Social Tagging
|
N/A | |
| Terminated |
NCT03537547 -
Combinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive Disorder
|
Phase 4 | |
| Terminated |
NCT04383509 -
Electroconvulsive Treatment Followed by Cognitive Control Training
|
N/A | |
| Completed |
NCT05683028 -
RCT for Electroconvulsive Treatment Followed by Cognitive Control Training
|
N/A | |
| Enrolling by invitation |
NCT05701345 -
Study of Virtual Reality-based Medical Device for Patients With Depressive Disorder
|
N/A | |
| Recruiting |
NCT04123301 -
Theta-Burst Stimulation in Major Depressive Episodes With Mixed Characteristics.
|
N/A | |
| Completed |
NCT05686408 -
Study to Evaluate TNX-601 ER Monotherapy Versus Placebo in Patients With Major Depressive Disorder (MDD)
|
Phase 2 | |
| Completed |
NCT03543410 -
A Clinical Study to Test the Effectiveness of an Investigational Drug to Treat People That Have Major Depressive Episodes When They Have Bipolar 1 Depression
|
Phase 2 | |
| Completed |
NCT04953338 -
Mental Health Associations With Vitiligo
|
||
| Completed |
NCT05462652 -
Self-guided Treatment for Adolescents Navigating Depression
|
N/A | |
| Recruiting |
NCT03944213 -
Resting-state Functional Connectivity Throughout a Course of iTBS in Major Depression
|